Ausgabe 6/2013
Inhalt (22 Artikel)
The evolving use of arsenic in pharmacotherapy of malignant disease
Athena Kritharis, Thomas P. Bradley, Daniel R. Budman
Prevalence and incidence of anemia in the German Heinz Nixdorf Recall Study
Lewin Eisele, Jan Dürig, Martina Broecker-Preuss, Ulrich Dührsen, Beate Bokhof, Raimund Erbel, Susanne Moebus, Karl-Heinz Jöckel
Hepatitis C in patients with β-thalassemia major. A single-centre experience
Christos Triantos, Alexandra Kourakli, Maria Kalafateli, Dimitra Giannakopoulou, Nikolaos Koukias, Konstantinos Thomopoulos, Polixeni Lampropoulou, Christina Bartzavali, Helen Fragopanagou, George C. Kagadis, Mirto Christofidou, Athanasios Tsamandas, Vasiliki Nikolopoulou, Marina Karakantza, Chryssoula Labropoulou-Karatza
Acute leukemias of ambiguous lineage in adults: molecular and clinical characterization
Sandra Heesch, Martin Neumann, Stefan Schwartz, Isabelle Bartram, Cornelia Schlee, Thomas Burmeister, Matthias Hänel, Arnold Ganser, Michael Heuser, Clemens-Martin Wendtner, Wolfgang E. Berdel, Nicola Gökbuget, Dieter Hoelzer, Wolf-Karsten Hofmann, Eckhard Thiel, Claudia D. Baldus
Hematologic malignancies with PCM1-JAK2 gene fusion share characteristics with myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB, and FGFR1
Verena Patterer, Susanne Schnittger, Wolfgang Kern, Torsten Haferlach, Claudia Haferlach
Clinical evaluation of the European LeukemiaNet response criteria in patients with essential thrombocythemia treated with anagrelide
Juan Carlos Hernández-Boluda, Arturo Pereira, Francisco Cervantes, Montse Gómez, Eduardo Arellano-Rodrigo, Alberto Alvarez-Larrán, Francisca Ferrer-Marín, Ana Kerguelen, José Antonio Márquez, María Luisa Antelo, Carles Besses
Functional inhibition of BCL2 is needed to increase the susceptibility to apoptosis to SMO inhibitors in diffuse large B-cell lymphoma of germinal center subtype
Kranthi Kunkalla, Yadong Liu, Changju Qu, Vasiliki Leventaki, Nitin K. Agarwal, Rajesh R. Singh, Francisco Vega
Autologous stem cell transplantation with busulfan, cyclophosphamide, and etoposide as an intensifying frontline treatment in patients with peripheral T cell lymphomas: a multicenter retrospective trial
Jae-Sook Ahn, Deok-Hwan Yang, Sung-Hoon Jung, Yee Soo Chae, Sang Kyun Sohn, Ho-Young Yhim, Jae-Yong Kwak, Se-Ryeon Lee, Yeo-Kyeoung Kim, Hyeoung-Joon Kim, Je-Jung Lee
Chromosomal abnormalities by conventional cytogenetics and interphase fluorescence in situ hybridization in chronic lymphocytic leukemia in Taiwan, an area with low incidence—clinical implication and comparison between the West and the East
Shang-Ju Wu, Chien-Ting Lin, Sheng-Yi Huang, Fen-Yu Lee, Ming-Chi Liu, Hsin-An Hou, Chien-Yuan Chen, Bor-Sheng Ko, Wen-Chien Chou, Ming Yao, Jih-Luh Tang, Woei Tsay, Hwei-Fang Tien
A retrospective analysis of primary gastric diffuse large B-cell lymphoma with or without concomitant mucosa-associated lymphoid tissue (MALT) lymphoma components
Xiaowu Li, Bing Xia, Shanqi Guo, Zhongli Zhan, Lianyu Zhang, Dandan Zhao, Xiaoxiong Wu, Yizhuo Zhang
The efficacy of rabbit antithymocyte globulin with cyclosporine in comparison to horse antithymocyte globulin as a first-line treatment in adult patients with severe aplastic anemia: a single-center retrospective study
Seung-Hwan Shin, Jae-Ho Yoon, Seung-Ah Yahng, Sung-Eun Lee, Byung-Sik Cho, Ki-Sung Eom, Yoo-Jin Kim, Seok Lee, Chang-Ki Min, Hee-Je Kim, Seok-Goo Cho, Dong-Wook Kim, Woo-Sung Min, Chong-Won Park, Jong Wook Lee
Modelling cost effectiveness of horse antithymocyte globulin for treating severe aplastic anaemia in Germany
Steffen Heublein, Franziska Wehner, Britta Höchsmann, Andreas Hochhaus, Michael Hartmann, Paul La Rosée
Second- versus first-generation azoles for antifungal prophylaxis in hematology patients: a systematic review and meta-analysis
Baohong Ping, Yangmin Zhu, Ya Gao, Chunyan Yue, Bin Wu
Haemophilia A associated with Down’s syndrome
Barbara Kaczorowska-Hac, Marek Wlazlowski, Jolanta Wierzba, Anna Balcerska
Molecular basis of primary iron overload in India and the role of serum-derived factors in hepcidin regulation
Rekha Athiyarath, Alok Srivastava, Eunice Sindhuvi Edison
Relapse of aHUS after discontinuation of therapy with eculizumab in a patient with aHUS and factor H mutation
Ryan Carr, Spero R. Cataland
Oligoclonal reconstitution masquerading as myeloma relapse
C. S. Chim, E. Y. T. Chan
Autoimmune hemolytic anemia with warm-reactive immunoglobulin M antibody in multicentric Castleman disease
Katsushi Tajima, Hisashi Yamamoto, Ikuko Suzuki, Yuichi Kato, Kanji Hatano, Shunji Takahashi, Makiko Sato, Takeo Kato
Pericardial effusion due to pericardium involvement by Hodgkin’s lymphoma
Salvatore Guastafierro, Salvatore Cappabianca, Umberto Falcone
Hodgkin’s lymphoma as a second cancer in multiple myeloma never exposed to lenalidomide
Chor Sang Chim, Pak Tat Choi, Wai Ki Lee
Successful allogeneic stem cell transplantation for Lennert lymphoma
Masahiro Uni, Akihide Yoshimi, Fumihiko Nakamura, Yutaka Takazawa, Masashi Fukayama, Mineo Kurokawa
Prognostic factors of primary gastric diffuse large B cell lymphoma: a retrospective study of 75 cases in China
Yong-xin Wu, Bo Liu, Li Chen, Jun-he Li, Shao-qing Chen